scholarly journals Pattern Recognition Receptor Ligands as an Emerging Therapeutic Agent for Latent HIV-1 Infection

2020 ◽  
Vol 10 ◽  
Author(s):  
Shokichi Takahama ◽  
Takuya Yamamoto
Keyword(s):  
Pattern Recognition ◽  
Therapeutic Agent ◽  
Pattern Recognition Receptor ◽  
Receptor Ligands ◽  
Latent Hiv ◽  
Hiv 1 ◽  
Recognition Receptor

scholarly journals A non-canonical role for the autophagy machinery in anti-retroviral signaling mediated by TRIM5α

2020 ◽  
Author(s):  
Bhaskar Saha ◽  
Devon Chisholm ◽  
Michael A Mandell
Keyword(s):  
Pattern Recognition ◽  
Pattern Recognition Receptor ◽  
Human Macrophage ◽  
Antiviral Defense ◽  
Species Barrier ◽  
Antiviral Signaling ◽  
Increased Risk ◽  
Hiv 1 ◽  
Recognition Receptor ◽  
In Cells

ABSTRACTTRIM5α is a key cross-species barrier to retroviral infection, with certain TRIM5 alleles conferring increased risk of HIV-1 infection in humans. TRIM5α is best known as a species-specific restriction factor that directly inhibits the viral life cycle. Additionally, it is also a pattern-recognition receptor (PRR) that activates inflammatory signaling. How TRIM5α carries out its multi-faceted actions in antiviral defense remains incompletely understood. Here, we show that proteins required for autophagy, a cellular self-digestion pathway, play an important role in TRIM5α’s function as a PRR. Genetic depletion of proteins involved in all stages of the autophagy pathway prevented TRIM5α-driven expression of NF-κB and AP1 responsive genes. One of these genes is the preeminent antiviral cytokine interferon β (IFN-β), whose TRIM5-dependent expression was lost in cells lacking the autophagy proteins ATG7, BECN1, and ULK1. Moreover, we found that the ability of TRIM5α to stimulate IFN-β expression in response to recognition of a TRIM5α-restricted HIV-1 capsid mutant (P90A) was abrogated in cells lacking autophagy factors. Stimulation of human macrophage-like cells with the P90A virus protected them against subsequent infection with an otherwise resistant wild type HIV-1 in a manner requiring TRIM5α, BECN1, and ULK1. Mechanistically, TRIM5α was attenuated in its ability to activate the kinase TAK1 in autophagy deficient cells, and both BECN1 and ATG7 contributed to the assembly of TRIM5α-TAK1 complexes. These data demonstrate a non-canonical role for the autophagy machinery in assembling antiviral signaling complexes and demonstrate a role for autophagy in the establishment of a TRIM5α-dependent antiviral state.SIGNIFICANCE STATEMENTTRIM5α is an antiretroviral protein that employs multiple mechanisms to protect cells against infection. Previous studies have linked TRIM5α to autophagy, a cytoplasmic quality control pathway with numerous roles in immunity, raising the possibility that TRIM5α engages autophagy in antiviral defense. This concept has been controversial, since TRIM5α’s best-known role as a directly acting antiretroviral effector is autophagy independent. However, retroviral restriction is only one aspect of TRIM5α function. We demonstrate that autophagy is crucial to another TRIM5α action: its role as a pattern-recognition receptor. We show that autophagy machinery is required for TRIM5α to transduce antiviral signaling and to establish an antiretroviral state. Our data indicate that autophagy provides TRIM5α with a platform upon which to activate antiviral responses.

Sign in / Sign up

Export Citation Format

Share Document